What is the best initial treatment for a positive Enterococcus (bacterial infection) infection on the epidermis (outer layer of skin)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Best Treatment for Enterococcus Infection on the Epidermis

For Enterococcus infections on the epidermis (skin), ampicillin is the first-line treatment when the organism is susceptible, with vancomycin as the alternative for resistant strains or in penicillin-allergic patients. 1

Initial Treatment Approach

  • Ampicillin or amoxicillin should be used as first-line therapy for susceptible Enterococcus faecalis infections on the skin 1
  • For penicillin-allergic patients or when resistance is suspected, vancomycin is the recommended alternative 1, 2
  • Piperacillin-tazobactam is another effective option for Enterococcus infections, particularly in polymicrobial skin infections 1, 2
  • Daptomycin is FDA-approved for complicated skin and skin structure infections caused by Enterococcus faecalis (vancomycin-susceptible isolates only) 3

Treatment Based on Resistance Pattern

For Susceptible Enterococcus:

  • Ampicillin or amoxicillin is the preferred treatment due to excellent efficacy and safety profile 1, 4
  • For uncomplicated skin infections, oral therapy may be sufficient after initial response 2

For Resistant Enterococcus:

  • Vancomycin for ampicillin-resistant but vancomycin-susceptible strains 1, 2
  • Linezolid or daptomycin for vancomycin-resistant Enterococcus (VRE) skin infections 4, 5
  • Tigecycline has demonstrated efficacy against Enterococcus faecalis in skin infections with a clinical cure rate of 71.4% 6

Special Considerations

  • For immunocompromised patients, broader empiric coverage may be necessary until culture results are available 1
  • In healthcare-associated infections, empiric anti-enterococcal therapy is recommended, particularly for patients who have previously received cephalosporins 2, 1
  • Cephalosporins should be avoided as monotherapy for Enterococcus infections due to intrinsic resistance 7, 8
  • For polymicrobial infections involving Enterococcus on the skin, combination therapy may be necessary to cover co-infecting organisms 2, 9

Treatment Duration

  • For uncomplicated skin infections: 7-10 days of appropriate therapy is typically sufficient 1
  • For complicated skin infections: 10-14 days of therapy is recommended 2
  • Clinical response should guide duration, with resolution of erythema, warmth, and swelling indicating successful treatment 2

Common Pitfalls to Avoid

  • Failure to obtain appropriate cultures before initiating antibiotics can lead to inadequate treatment 2
  • Using cephalosporins alone for Enterococcus infections is ineffective due to intrinsic resistance 7, 8
  • Underestimating the importance of Enterococcus in polymicrobial skin infections can lead to treatment failure 9
  • Delayed recognition of vancomycin-resistant Enterococcus requiring alternative agents like linezolid or daptomycin 4, 5

By following these evidence-based recommendations, clinicians can effectively treat Enterococcus infections on the epidermis while minimizing the risk of treatment failure and antimicrobial resistance.

References

Guideline

Management of Enterococcus Infections in Patients with Colon Cancer

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Approaches to vancomycin-resistant enterococci.

Current opinion in infectious diseases, 2004

Research

The life and times of the Enterococcus.

Clinical microbiology reviews, 1990

Research

Antibiotic-resistant enterococci.

The Journal of hospital infection, 1992

Research

Clinical manifestations of enterococcal infection.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1990

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.